The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

Impaired antibody response in an AIDS patient compromised the accuracy of the test. The OraQuick Advance Rapid HIV-1 Antibody Test has transformed HIV testing from a cumbersome process to a rapid ...

Knowing how to leverage these technologies means we can help set the new standard and inform the next evolution of HIV care.

Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. None of the roughly 2,000 women in the trial who received the ...